Cardiol Therapeutics Cash Flow Statement (2021-2022) | CRDL

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022
Operating Activities
Depreciation and Depletion	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M
Share-based Compensation	1.69M	2.07M	0.14M	3.64M	0.84M	0.07M	0.15M
Cash from Operations	-5.60M	-4.94M	-5.07M	-3.17M	-8.22M	-2.01M	-1.30M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M
Change in Working Capital
Change in Account Payables	0.19M	2.34M	-0.28M	3.86M	0.57M	1.62M	5.87M
Other Working Capital Changes	-0.94M	1.77M	0.48M	1.98M	-0.45M	0.50M	1.10M
Investing Activities
Cash from Investing Activities			0.01M		-0.01M	-0.00M	-0.01M
Financing Activities
Other financing activities				-3.06M
Cash from Financing Activities	8.74M	16.91M	1.85M	47.01M	-0.01M	-0.01M	-0.01M
Additional items
Exchange Rate Effect					1.10M	-1.42M	-2.46M
Beginning Cash Balance	3.14M	32.72M	11.62M	66.56M	-8.24M	-10.22M	-11.30M
Free Cash Flow	-5.60M	-4.94M	-5.07M	-3.17M	-8.22M	-2.01M	-1.30M
Net Cash Flow	3.14M	11.97M	-3.21M	43.84M	-8.24M	-2.03M	-1.32M